Dietary factors modulate helicobacter-associated gastric cancer in rodent models

Toxicologic Pathology

Volumn 42, Issue 1, 2014, Pages 162-181

  Fox, James G ^a   Wang, Timothy C ^b  

^a Massachusetts Institute of Technology   (United States)

^b Department of Medicine   (United States)

Author keywords

diet; gerbils; Helicobacter felis; Helicobacter pylori; mice

Indexed keywords

ASCORBIC ACID; FAT; FOLIC ACID; GASTRIN; IRON; SODIUM CHLORIDE;

ANIMAL MODEL; ARTICLE; CHRONIC GASTRITIS; DIET; DISEASE COURSE; DISEASE SEVERITY; GENETIC MANIPULATION; GERBIL; HELICOBACTER FELIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IRON DEFICIENCY; MERIONES UNGUICULATUS; MOUSE; MOUSE MODEL; NONHUMAN; PATHOGENESIS; PATHOGENICITY ISLAND; PRIORITY JOURNAL; RODENT MODEL; STOMACH CANCER;

DIET; GERBILS; HELICOBACTER FELIS; HELICOBACTER PYLORI; MICE;

ANIMALS; ASCORBIC ACID; DEVELOPING COUNTRIES; DIET; DIETARY FATS; DISEASE MODELS, ANIMAL; FOLIC ACID; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICE; SALTS; STOMACH NEOPLASMS;

EID: 84892696157     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623313512564     Document Type: Article

References (200)

1. Ahmed N., Sechi L. A.. Helicobacter pylori and gastroduodenal pathology: New threats of the old friend. Annals Clin Microbiol Antimicrob. 2005 ; 4: 1
2. Akiba S., Neriishi K., Blot W. J., Kabuto M., Stevens R. G., Kato H., Land C. E. Serum ferritin and stomach cancer risk among a Japanese population. Cancer. 1991 ; 67: 1707
3. Annibale B., Capurso G., Lahner E., Passi S., Ricci R., Maggio F., Delle Fave G. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. GUT. 2003 ; 52: 496-501
4. Arnold I. C., Lee J. Y., Amieva M. R., Roers A., Flavell R. A., Sparwasser T., Muller A. Tolerance rather than immunity protects from Helicobacterpylori-induced gastric preneoplasia. Gastroenterology. 2011 ; 140: 199-209
5. Asfaha S., Dubeykovskiy A. N., Tomita H., Yang X., Stokes S., Shibata W., Friedman R. A., Ariyama H., Dubeykovskaya Z. A., Muthupalani S., Ericksen R., Frucht H., Fox J. G., Wang T. C. Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis. Gastroenterology. 2013 ; 144: 155-66
6. Barabino A., Dufour C., Marino C. E., Claudiani F., De Alessandri A. Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: Further clinical evidence. J Pediatr Gastroenterol Nutr. 1999 ; 28: 116-19
7. Bartsch H., Ohshima H., Pignatelli B. Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. Mut Res. 1988 ; 202: 307-24
8. Bates C. J., Prentice A. M., Paul A. A.. Seasonal variations in vitamins A, C, riboflavin and folate intakes and status of pregnant and lactating women in a rural Gambian community: Some possible implications. Eur J Clin Nutr. 1994 ; 48: 660-68
9. Bergin I. L., Sheppard B. J., Fox J. G.. Helicobacter pylori infection and high dietary salt independently induce atrophic gastritis and intestinal metaplasia in commercially available outbred Mongolian gerbils. Dig Dis Sci. 2003 ; 48: 475-85
10. Berretta M., Cappellani A., Lleshi A., Di Vita M., Lo Menzo E., Bearz A., Galvano F., Spina M., Malaguarnera M., Tirelli U., Berretta S.. The role of diet in gastric cancer: Still an open question. Front Biosci. 2012 ; 17: 1640-47
11. Bjelakovic G., Nikolova D., Simonetti R.G., Gluud C.. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet. 2004 ; 364: 1219-28
12. Brandt S., Kwok T., Hartig R., Konig W., Backert S.. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA. 2005 ; 102: 9300-5
13. Brandt S., Shafikhani S., Balachandran P., Jin S., Hartig R., Konig W., Engel J., Backert S.. Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacterpylori-induced host cell actin cytoskeletal rearrangements. FEMS Immunol Med Microbiol. 2007 ; 50: 190-205
14. Brenner H., Rothenbacher D., Arndt V.. Epidemiology of stomach cancer. Methods Mol Biol. 2009 ; 472: 467-77
15. Buiatti E., Palli D., Decarli A., Amadori D., Avellini C., Bianchi S., Bonaguri C., Cipriani F., Cocco P., Giacosa A., Marubini E., Puntoni R., Vindigni C., Fraumeni J.F., Blot W.. A case-control study of gastric cancer and diet in Italy: I. Frequencies of food consumption. Int J Cancer. 1990 ; 44: 611-16
16. Cai X., Carlson J., Stoicov C., Li H., Wang T. C., Houghton J.. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology. 2005 ; 128: 1937-52
17. Camargo M. C., Mera R., Correa P., Peek R. M., Fontham E. T., Goodman K. J., Piazuelo M. B., Sicinschi L., Zabaleta J., Schneider B. G.. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006 ; 15: 1674-87
18. Charlton R. W., Bothwell T. H.. Iron absorption. Annual Rev Med. 1983 ; 34: 55-68
19. Charnley G., Tannenbaum S. R.. Flow cytometric analysis of the effect of sodium chloride on gastric cancer risk in the rat. Cancer Res. 1985 ; 45: 5608-16
20. Chen V. W., Abu-Elyazeed R. R., Zavala D. E., Haenszel W., Ktsanes V. K., Rice J., Cuello C., Montes G., Correa P.. Risk factors of gastric precancerous lesions in a high-risk Colombian population. II. Nitrate and nitrite. Nutr Cancer. 1990 ; 13: 67-72
21. Choe Y. H., Kim S. K., Son B. K., Lee D. H., Hong Y. C., Pai S. H.. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter. 1999 ; 4: 135-39
22. Choe Y. H., Lee J. E., Kim S. K.. Effect of Helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection. Acta Paediatr. 2000 ; 89: 154-57
23. Chung W. K., Leibel R. L.. The links between obesity, leptin, and prostate cancer. Cancer J. 2006 ; 12: 178-81
24. Collins S., Martin T. L., Surwit R. S., Robidoux J.. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: Physiological and molecular characteristics. Physiol Behav. 2004 ; 81: 243-48
25. Correa P. Diet and Human Carcinogenesis. 1985 ). Mechanisms of gastric carcinogenesis. In Diet and Human Carcinogenesis (JoossensJ. V.HillM. J.GeboersJ., eds.), pp. 109-115. Elsevier, Amsterdam, the Netherlands. Joossens J. V. Hill M. J. Geboers J., ed. Amsterdam, the Netherlands: Elsevier ; 1985: 109-115.
26. Correa P.. Is gastric carcinoma an infectious disease?. N Engl J of Med. 1991 ; 325: 1170-1171
27. Correa P., Fontham E. T., Bravo J. C., Bravo L. E., Ruiz B., Zarama G., Realpe J. L., Malcom G. T., Li D., Johnson W. D., Mera R.. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 2000 ; 92: 1881-88
28. Correa P., Fontham E., Pickle L. W., Chen V., Lin Y. P., Haenszel W.. Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst. 1985 ; 75: 645-54
29. Correa P., Malcom G., Schmidt B., Fontham E., Ruiz B., Bravo J. C., Bravo L. E., Zarama G., Realpe J. L.. Review article: Antioxidant micronutrients and gastric cancer. Aliment Pharmacol Ther. 1998 ; 12: 73-82
30. Court M., Robinson P. A., Dixon M. F., Crabtree J. E.. Gastric Helicobacter species infection in murine and gerbil models: Comparative analysis of effects of H. pylori and H. felis on gastric epithelial cell proliferation. J Infect Dis. 2002 ; 186: 1348-52
31. Covacci A., Censini S., Bugnoli M., Petracca R., Burroni D., Macchia G., Massone A., Papini E., Xiang Z., Figura N., Rappuoli R.. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA. 1993 ; 90: 5791-95
32. Cover T. L., Blaser M. J.. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 1992 ; 267: 10570-75
33. Cravo M., Pinto R., Fidalgo P., Chaves P., Gloria L., Nobre-Leitao C., Costa Mira F.. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. GUT. 1996 ; 39: 434-38
34. Cui G., Houghton J., Finkel N., Carlson J., Wang T. C.. IFN-gamma infusion induces gastric atrophy, metaplasia and dysplasia in the absence of Helicobacter infection-a role for immune response in Helicobacter disease. Gastroenterology. 2003 ; 124: A19
35. Cui G., Koh T. J., Chen D., Zhao C. M., Takaishi S., Dockray G. J., Varro A., Rogers A. B., Fox J. G., Wang T. C.. Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res. 2004 ; 64: 8160-66
36. Cui G., Takaishi S., Ai W., Betz K. S., Florholmen J., Koh T. J., Houghton J., Pritchard D. M., Wang T. C.. Gastrin-induced apoptosis contributes to carcinogenesis in the stomach. Lab Invest. 2006 ; 86: 1037-51
37. D'Elia L., Rossi G., Ippolito R., Cappuccio F. P., Strazzullo P.. Habitual salt intake and risk of gastric cancer: A meta-analysis of prospective studies. Clin Nutr. 2012 ; 31: 489-98
38. D'Elios M. M., Manghetti M., De Carli M., Costa F., Baldari C. T., Burroni D., Telford J. L., Romagnani S., Del Prete G.. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol. 1997 ; 158: 962-67
39. Doenges J. L.. Spirochaetes in the gastric glands of the Macaus Rhesus and human without definite history of related disease. Exp Biol Med. 1938 ; 38: 536-38
40. El-Omar E. M., Carrington M., Chow W. H., McColl K. E., Bream J. H., Young H. A., Herrera J., Lissowska J., Yuan C. C., Rothman N., Lanyon G., Martin M., Fraumeni J. F., Rabkin C. S.. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000 ; 404: 398-402
41. El-Omar E. M., Rabkin C. S., Gammon M. D., Vaughan T. L., Risch H. A., Schoenberg J. B., Stanford J. L., Mayne S. T., Goedert J., Blot W. J., Fraumeni J. F., Chow W. H.. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003 ; 124: 1193-201
42. Ericksen R. E., Rose S., Westphalen C. B., Shibata W., Muthupalani S., Tailor Y., Friedman R. A., Han W., Fox J. G., Ferrante A. W., Wang T. C. Obesity accelerates Helicobacterfelis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response. GUT. 2013 ;:
43. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 ; 127: 2893-917
44. Ferrante A. W.. Obesity-induced inflammation: A metabolic dialogue in the language of inflammation. J Intern Med. 2007 ; 262: 408-14
45. Foo J. H., Culvenor J. G., Ferrero R. L., Kwok T., Lithgow T., Gabriel K.. Both the p33 and p55 subunits of the Helicobacter pylori VacA toxin are targeted to mammalian mitochondria. J Mol Biol. 2010 ; 401: 792-98
46. Fox J. G., Beck P., Dangler C. A., Whary M. T., Wang T. C., Shi H. N., Nagler-Anderson C.. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med. 2000 ; 6: 536-42
47. Fox J. G., Blanco M., Murphy J. C., Taylor N. S., Lee A., Kabok Z., Pappo J.. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun. 1993 ; 61: 2309-15
48. Fox J. G., Dangler C. A., Taylor N. S., King A., Koh T. J., Wang T. C.. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res. 1999 ; 59: 4823-28
49. Fox J. G., Kuipers E. J.. Long-term proton pump inhibitor administration, H pylori and gastric cancer: Lessons from the gerbil. GUT. 2011 ; 60: 567-68
50. Fox J. G., Lee A., Otto G., Taylor N. S., Murphy J. C.. Helicobacter felis gastritis in gnotobiotic rats: An animal model of Helicobacter pylori gastritis. Infect Immun. 1991 ; 59: 785-91
51. Fox J. G., Rogers A. B., Ihrig M., Taylor N. S., Whary M. T., Dockray G., Varro A., Wang T. C.. Helicobacterpylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res. 2003 ; 63: 942-50
52. Fox J. G., Sheppard B. J., Dangler C. A., Whary M. T., Ihrig M., Wang T. C.. Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses. Cancer Res. 2002 ; 62: 696-702
53. Fox J. G., Wang T. C.. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007 ; 117: 60-69
54. Fox J. G., Wang T. C., Rogers A. B., Poutahidis T., Ge Z., Taylor N., Dangler C. A., Israel D. A., Krishna U., Gaus K., Peek R. M.. Host and microbial constituents influence Helicobacterpylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology. 2003 ; 124: 1879-90
55. Franco A. T., Israel D. A., Washington M. K., Krishna U., Fox J. G., Rogers A. B., Neish A. S., Collier-Hyams L., Perez-Perez G. I., Hatakeyama M., Whitehead R., Gaus K., O'Brien D. P., Romero-Gallo J., Peek R. M.,. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA. 2005 ; 102: 10646-51
56. Freedberg A. S., Barron L.. The presence of spirochetes in human gastric mucosa. Am J Dig Dis. 1940 ; 7: 443-45
57. Friedman G. D., Parsonnet J.. Salt intake and stomach cancer: Some contrary evidence. Cancer Epidemiol Biomarkers Prev. 1992 ; 1: 607-8
58. Furihata C., Sato Y., Hosaka M., Matsushima T., Furukawa F., Takahashi M.. NaCl induced ornithine decarboxylase and DNA synthesis in rat stomach mucosa. Biochem Biophys Res Commun. 1984 ; 121: 1027-32
59. Gaddy J. A., Radin J. N., Loh J. T., Zhang F., Washington M. K., Peek R. M., Algood H. M., Cover T. L.. High dietary salt intake exacerbates Helicobacterpylori-induced gastric carcinogenesis. Infect Immun. 2013 ; 81: 2258-67
60. Gaut J. P., Belaaouaj A., Byun J., Roberts L. J., Maeda N., Frei B., Heinecke J. W.. Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation. Free Radic biol Med. 2006 ; 40: 1494-501
61. Ge Z., Feng Y., Muthupalani S., Eurell L. L., Taylor N. S., Whary M. T., Fox J. G.. Coinfection with enterohepatic Helicobacter species can ameliorate or promote Helicobacterpylori-induced gastric pathology in C57BL/6 mice. Infect Immun. 2011 ; 79: 3861-71
62. Geboers J., Joossens J. V., Kesteloot H. Diet and Human Carcinogenesis. Joossens J. V. Hill M. J. Geboers J., ed. Amsterdam, the Netherlands: Elsevier ; 1985: 81-95.
63. Gonda T. A., Kim Y. I., Salas M. C., Gamble M. V., Shibata W., Muthupalani S., Sohn K. J., Abrams J. A., Fox J. G., Wang T. C., Tycko B.. Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterology. 2012 ; 142: 824-33 e827
64. Gwack J., Shin A., Kim C. S., Ko K. P., Kim Y., Jun J. K., Bae J., Park S. K., Hong Y. C., Kang D., Chang S. H., Shin H. R., Yoo K. Y.. CagA-producing Helicobacter pylori and increased risk of gastric cancer: A nested case-control study in Korea. Br J Cancer. 2006 ; 95: 639-41
65. Hagiwara T., Mukaisho K., Nakayama T., Sugihara H., Hattori T.. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. GUT. 2011 ; 60: 624-30
66. Hansson L. E., Nyren O., Hsing A. W., Bergstrom R., Josefsson S., Chow W. H., Fraumeni J. F., Adami H. O.. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996 ; 335: 242-49
67. Harrison L. E., Zhang Z. F., Karpeh M. S., Sun M., Kurtz R. C.. The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: A case-control study in the U.S. Cancer. 1997 ; 80: 1021-28
68. Hemila H., Kaprio J., Pietinen P., Albanes D., Heinonen O. P.. Vitamin C and other compounds in vitamin C rich food in relation to risk of tuberculosis in male smokers. Am J Epidemiol. 1999 ; 150: 632-41
69. Hirayama F., Takagi S., Kusuhara H., Iwao E., Yokoyama Y., Ikeda Y.. Induction of gastric ulcer and intestinal metaplasia in mongolian gerbils infected with Helicobacter pylori. J Gastroenterol. 1996 ; 31: 755-57
70. Holcombe C.. Helicobacter pylori: The African enigma. GUT. 1992 ; 33: 429-31
71. Honda S., Fujioka T., Tokieda M., Gotoh T., Nishizono A., Nasu M.. Gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scand J Gastroenterol. 1998 ; 33: 454-60
72. Honda S., Fujioka T., Tokieda M., Satoh R., Nishizono A., Nasu M.. Development of Helicobacterpylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 1998 ; 58: 4255-59
73. Hou L., Wang H., Sartori S., Gawron A., Lissowska J., Bollati V., Tarantini L., Zhang F. F., Zatonski W., Chow W. H., Baccarelli A.. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer. 2010 ; 127: 1866-74
74. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, Liver Flukes and Helicobacter Pylori. Lyon, France: International Agency for Research on Cancer ; 1994 :
75. James B. R., Tomanek-Chalkley A., Askeland E. J., Kucaba T., Griffith T. S., Norian L. A.. Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth. J Immunol. 2012 ; 189: 1311-21
76. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D.. Global cancer statistics. CA Cancer J Clin. 2011 ; 61: 69-90
77. Jones K. R., Whitmire J. M., Merrell D. S.. A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease. Front Microbiol. 2010 ; 1: 115
78. Joossens J. V., Geboers J.. Nutrition and gastric cancer. Nutr Cancer. 1981 ; 2: 250-61
79. Judd L. M., Alderman B. M., Howlett M., Shulkes A., Dow C., Moverley J., Grail D., Jenkins B. J., Ernst M., Giraud A. S.. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology. 2004 ; 126: 196-207
80. Kanneganti T. D., Dixit V. D.. Immunological complications of obesity. Nat Immunol. 2012 ; 13: 707-12
81. Karita M., Kouchiyama T., Okita K., Nakazawa T.. New small animal model for human gastric Helicobacter pylori infection: Success in both nude and euthymic mice. Am J Gastroenterol. 1991 ; 86: 1596-603
82. Keenan J. I., Peterson R. A., Fraser R., Frampton C. M., Walmsley T. A., Allardyce R. A., Roake J. A.. The effect of Helicobacter pylori infection and dietary iron deficiency on host iron homeostasis: A study in mice. Helicobacter. 2004 ; 9: 643-50
83. Kim Y. I.. Folate and DNA methylation: A mechanistic link between folate deficiency and colorectal cancer?. Cancer Epidemiol Biomarkers Prev. 2004 ; 13: 511-19
84. Kodama M., Kodama T., Suzuki H., Kondo K.. Effect of rice and salty rice diets on the structure of mouse stomach. Nutr Cancer. 1984 ; 6: 135-47
85. Krejs G. J.. Gastric cancer: Epidemiology and risk factors. Dig Dis. 2010 ; 28: 600-3
86. Kuipers E. J.. Proton pump inhibitors and gastric neoplasia. GUT. 2006 ; 55: 1217-21
87. Kuipers E. J., Lundell L., Klinkenberg-Knol E. C., Havu N., Festen H. P., Liedman B., Lamers C. B., Jansen J. B., Dalenback J., Snel P., Nelis G. F., Meuwissen S. G.. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996 ; 334: 1018-22
88. Kuipers E. J., Uyterlinde A. M., Pena A. S., Hazenberg H. J., Bloemena E., Lindeman J., Klinkenberg-Knol E. C., Meuwissen S. G.. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-term safety. Am J Gastroenterol. 1995 ; 90: 1401-6
89. Kurekci A. E., Atay A. A., Sarici S. U., Yesilkaya E., Senses Z., Okutan V., Ozcan O.. Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia?. J Trop Pediatr. 2005 ; 51: 166-69
90. Lastovica A. J., le Roux E.. Efficient isolation of campylobacteria from stools. J Clin Microbiol. 2000 ; 38: 2798-99
91. La Vecchia C., Negri E., Decarli A., D'Avanzo B., Franceschi S.. A case-control study of diet and gastric cancer in northern Italy. Int J Cancer. 1987 ; 40: 484-89
92. Lee A., Fox J. G., Otto G., Murphy J.. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology. 1990 ; 99: 1315-23
93. Lee S. A., Kang D., Shim K. N., Choe J. W., Hong W. S., Choi H.. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol. 2003 ; 13: 162-68
94. Lee I. O., Kim J. H., Choi Y. J., Pillinger M. H., Kim S. Y., Blaser M. J., Lee Y. C.. Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J Biol Chem. 2010 ; 285: 16042-50
95. Lee A., Krakowka S., Fox J. G., Otto G., Eaton K. A., Murphy J. C.. Role of Helicobacter felis in chronic canine gastritis. Vet Pathol. 1992 ; 29: 487-94
96. Lee A., O'Rourke J., De Ungria M. C., Robertson B., Daskalopoulos G., Dixon M. F.. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain. Gastroenterology. 1997 ; 112: 1386-97
97. Lee C. W., Wang X. D., Chien K. L., Ge Z., Rickman B. H., Rogers A. B., Varro A., Whary M. T., Wang T. C., Fox J. G.. Vitamin C supplementation does not protect L-gulono-gamma-lactone oxidase-deficient mice from Helicobacter pylori-induced gastritis and gastric premalignancy. Int J Cancer. 2008 ; 122: 1068-76
98. Lemke L. B., Ge Z., Whary M. T., Feng Y., Rogers A. B., Muthupalani S., Fox J. G.. Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology. Infect Immun. 2009 ; 77: 2147-58
99. Lertpiriyapong K., Whary M. T., Muthupalani S., Lofgren J. L., Gamazon E. R., Feng Y., Ge Z., Wang T. C., Fox J. G. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. GUT. In Press ;:
100. Leunk R. D., Johnson P. T., David B. C., Kraft W. G., Morgan D. R.. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol. 1988 ; 26: 93-99
101. Levi S., Beardshall K., Haddad G., Playford R., Ghosh P., Calam J.. Campylobacter pylori and duodenal ulcers: The gastrin link. Lancet. 1989 ; 1: 1167-68
102. Li Q., Karam S. M., Gordon J. I.. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem. 1996 ; 271: 3671-76
103. Li W., Maeda N., Beck M. A.. Vitamin C deficiency increases the lung pathology of influenza virus-infected gulo-/- mice. J Nutr. 2006 ; 136: 2611-16
104. Liao J. H., Sun Y. H., Hsu C. H., Lin Y. C., Wu S. H., Kuo C. J., Huang C. H., Chiou S. H.. Up-regulation of neutrophil activating protein in Helicobacter pylori under high-salt stress: Structural and phylogenetic comparison with bacterial iron-binding ferritins. Biochimie. 2013 ; 95: 1136-45
105. Lofgren J. L., Whary M. T., Ge Z., Muthupalani S., Taylor N. S., Mobley M., Potter A., Varro A., Eibach D., Suerbaum S., Wang T. C., Fox J. G.. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology. 2011 ; 140: 210-20
106. Loh J. T., Friedman D. B., Piazuelo M. B., Bravo L. E., Wilson K. T., Peek R. M., Correa P., Cover T. L.. Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression. Infect Immun. 2012 ; 80: 3094-106
107. Lundell L., Havu N., Miettinen P., Myrvold H. E., Wallin L., Julkunen R., Levander K., Hatlebakk J. G., Liedman B., Lamm M., Malm A., Walan A.. Changes of gastric mucosal architecture during long-term omeprazole therapy: Results of a randomized clinical trial. Aliment Pharmacol Ther. 2006 ; 23: 639-47
108. Marchetti M., Arico B., Burroni D., Figura N., Rappuoli R., Ghiara P.. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 1995 ; 267: 1655-58
109. Marignani M., Angeletti S., Bordi C., Malagnino F., Mancino C., Delle Fave G., Annibale B.. Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. Scand J Gastroenterol. 1997 ; 32: 617-22
110. Martin H. R., Shakya K. P., Muthupalani S., Ge Z., Klei T. R., Whary M. T., Fox J. G.. Brugia filariasis differentially modulates persistent Helicobacter pylori gastritis in the gerbil model. Microbes Infect. 2010 ; 12: 748-58
111. Mera R., Fontham E. T., Bravo L. E., Bravo J. C., Piazuelo M. B., Camargo M. C., Correa P.. Long term follow up of patients treated for Helicobacter pylori infection. GUT. 2005 ; 54: 1536-40
112. Mimuro H., Suzuki T., Tanaka J., Asahi M., Haas R., Sasakawa C.. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol cell. 2002 ; 10: 745-55
113. Mohammadi M., Nedrud J., Redline R., Lycke N., Czinn S. J.. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology. 1997 ; 113: 1848-57
114. Mohammadi M., Redline R., Nedrud J., Czinn S.. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun. 1996 ; 64: 238-45
115. Moon H. S., Liu X., Nagel J. M., Chamberland J. P., Diakopoulos K. N., Brinkoetter M. T., Hatziapostolou M., Wu Y., Robson S. C., Iliopoulos D., Mantzoros C. S.. Salutary effects of adiponectin on colon cancer: In vivo and in vitro studies in mice. GUT. 2013 ; 62: 561-70
116. Mulholland G., Ardill J. E., Fillmore D., Chittajallu R. S., Fullarton G. M., McColl K. E.. Helicobacter pylori related hypergastrinemia is the result of selective increase in gastrin 17. Gut. 1993 ; 34: 757-61
117. Muller A The Biology of Gastric Cancers. Wang T. C. Fox J. G. Giraud A. S., ed. Springer, New York, NY: ; 2009: 91.
118. Muller A.. Multistep activation of the Helicobacter pylori effector CagA. J Clin Invest. 2012 ; 122: 1192-95
119. Newberne P. M., Charnley G., Adams K., Cantor M., Suphakarn V., Roth D., Schrager T. F.. Gastric carcinogenesis: A model for the identification of risk factors. Cancer Lett. 1987 ; 38: 149-63
120. Niwa T., Toyoda T., Tsukamoto T., Mori A., Tatematsu M., Ushijima T.. Prevention of Helicobacter pylori-induced gastric cancers in gerbils by a DNA demethylating agent. Cancer Prev Res (Phila). 2013 ; 6: 263-70
121. Noto J. M., Gaddy J. A., Lee J. Y., Piazuelo M. B., Friedman D. B., Colvin D. C., Romero-Gallo J., Suarez G., Loh J., Slaughter J. C., Tan S., Morgan D. R., Wilson K. T., Bravo L. E., Correa P., Cover T. L., Amieva M. R., Peek R. M.. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clinical Invest. 2013 ; 123: 479-92
122. Nozaki K., Shimizu N., Inada K., Tsukamoto T., Inoue M., Kumagai T., Sugiyama A., Mizoshita T., Kaminishi M., Tatematsu M.. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res. 2002 ; 93: 1083-89
123. Ohgaki H., Szentirmay Z., Take M., Sugimura T.. Effects of 4-week treatment with gastric carcinogens and enhancing agents on proliferation of gastric mucosa cells in rats. Cancer Lett. 1989 ; 46: 117-22
124. Ohkusa T., Okayasu I., Miwa H., Ohtaka K., Endo S., Sato N.. Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils. GUT. 2003 ; 52: 797-803
125. Ohtani M., Garcia A., Rogers A. B., Ge Z., Taylor N. S., Xu S., Watanabe K., Marini R. P., Whary M. T., Wang T. C., Fox J. G.. Protective role of 17 beta-estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. Carcinogenesis. 2007 ; 28: 2597-604
126. Ohtani M., Ge Z., Garcia A., Rogers A. B., Muthupalani S., Taylor N. S., Xu S., Watanabe K., Feng Y., Marini R. P., Whary M. T., Wang T. C., Fox J. G. 17 Beta-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice. Carcinogenesis. 2011 ; 32: 1244-50
127. Oliveira M. J., Costa A. M., Costa A. C., Ferreira R. M., Sampaio P., Machado J. C., Seruca R., Mareel M., Figueiredo C.. CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype. J Infect Dis. 2009 ; 200: 745-55
128. Ostrand-Rosenberg S., Sinha P.. Myeloid-derived suppressor cells: Linking inflammation and cancer. J Immunol. 2009 ; 182: 4499-506
129. Phull P. S., Price A. B., White K. L., Schorah C. J., Jacyna M. R.. Gastroduodenal mucosal vitamin-C levels in Helicobacter pylori infection. Scand J Gastroenterol. 1999 ; 34: 361-66
130. Poppe M., Feller S. M., Romer G., Wessler S.. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene. 2007 ; 26: 3462-72
131. Pra D., Rech Franke S. I., Pegas Henriques J. A., Fenech M.. A possible link between iron deficiency and gastrointestinal carcinogenesis. Nutr Cancer. 2009 ; 61: 415-26
132. Przemeck S. M., Varro A., Berry D., Steele I., Wang T. C., Dockray G. J., Pritchard D. M.. Hypergastrinemia increases gastric epithelial susceptibility to apoptosis. Regul Pept. 2008 ; 146: 147-56
133. Pylayeva-Gupta Y., Lee K. E., Hajdu C. H., Miller G., Bar-Sagi D.. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell. 2012 ; 21: 836-47
134. Rieder G., Merchant J. L., Haas R.. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology. 2005 ; 128: 1229-42
135. Rogers A. B., Fox J. G.. Inflammation and cancer I. Rodent models of infectious gastrointestinal and liver cancer. Am J Physiol Gastrointest Liver Physiol. 2004 ; 286: G361-66
136. Rogers A. B., Taylor N. S., Whary M. T., Stefanich E. D., Wang T. C., Fox J. G.. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res. 2005 ; 65: 10709-15
137. Roth K. A., Kapadia S. B., Martin S. M., Lorenz R. G.. Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology. J Immunol. 1999 ; 163: 1490-97
138. Sakagami T., Shimoyama T., O'Rouke J.. Back to the host: Severity of inflammation induced by Helicobacter felis in different strains of mice. Am J Gastroenterol. 1994 ; 89: 1345
139. Sato T., Fukuyama T., Urata F.. Studies of the causation of gastric cancer. I. Bleeding in the glandular stomach of mice by feeding with highly salted foods, and a comment on salted foods in Japan. Jap Med J. 1959) ; 1835: 5
140. Schmidt P. H., Lee J. R., Goldenring, Wright N. A., Poulsom R.. Association of an aberrant spasmolytic peptideexpressing cell lineage with gastric adenocarcinoma in humans. Gastroenterology. 1998 ; 114: A673
141. Schwager J., Schulze J.. Modulation of interleukin production by ascorbic acid. Vet Immunol Immunopathol. 1998 ; 64: 45-57
142. Schwarz P., Kubler J. A., Strnad P., Muller K., Barth T. F., Gerloff A., Feick P., Peyssonnaux C., Vaulont S., Adler G., Kulaksiz H.. Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection. GUT. 2012 ; 61: 193-201
143. Senkovich O., Ceaser S., McGee D. J., Testerman T. L.. Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media. Infect Immun. 2010 ; 78: 1841-49
144. Sheh A., Ge Z., Parry N. M., Muthupalani S., Rager J. E., Raczynski A. R., Mobley M. W., McCabe A. F., Fry R. C., Wang T. C., Fox J. G. 17 Beta-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice. Cancer Prev Res (Phila). 2011 ; 4: 1426-35
145. Shi Y., Liu X. F., Zhuang Y., Zhang J. Y., Liu T., Yin Z., Wu C., Mao X. H., Jia K. R., Wang F. J., Guo H., Flavell R. A., Zhao Z., Liu K. Y., Xiao B., Guo Y., Zhang W. J., Zhou W. Y., Guo G., Zou Q. M.. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol. 2010 ; 184: 5121-29
146. Shitara K., Muro K., Ito S., Sawaki A., Tajika M., Kawai H., Yokota T., Takahari D., Shibata T., Ura T., Ito H., Hosono S., Kawase T., Watanabe M., Tajima K., Yatabe Y., Tanaka H., Matsuo K.. Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer. Cancer Epidemiol Biomarkers Prev. 2010 ; 19: 1311-19
147. Shomer N. H., Dangler C. A., Whary M. T., Fox J. G.. Experimental Helicobacter pylori infection induces antral gastritis and gastric mucosa-associated lymphoid tissue in guinea pigs. Infect Immun. 1998 ; 66: 2614-18
148. Smythies L. E., Waites K. B., Lindsey J. R., Harris P. R., Ghiara P., Smith P. D.. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol. 2000 ; 165: 1022-29
149. Sobala G. M., Pignatelli B., Schorah C. J.. Simultaneous determination of ascorbic acid nitrite, total nitrosocompounds and bile acids in fasting gastric juice, and gastric mucosal histology implications for gastric carcinogenesis. Carcinogenesis. 1991 ; 14: 291-92
150. Sobala G. M., Schorah C. J., Pignatelli B., Crabtree J. E., Martin I. G., Scott N., Quirke P.. High gastric juice ascorbic acid concentrations in members of a gastric cancer family. Carcinogenesis. 1993 ; 14: 291-92
151. Song J., Medline A., Mason J. B., Gallinger S., Kim Y. I.. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res. 2000 ; 60: 5434-40
152. Song J., Sohn K. J., Medline A., Ash C., Gallinger S., Kim Y. I..
153. Sorbye H., Svanes C., Stangeland L., Kvinnsland S., Svanes K.. Epithelial restitution and cellular proliferation after gastric mucosal damage caused by hypertonic NaCl in rats. Virchows Archiv. 1988 ; 413: 445-55
154. Steele I. A., Dimaline R., Pritchard D. M., Peek R. M., Wang T. C., Dockray G. J., Varro A.. Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements. Am J Physiol Gastrointest Liver Physiol. 2007 ; 293: G347-54
155. Stenstrom B., Zhao C. M., Rogers A. B., Nilsson H. O., Sturegard E., Lundgren S., Fox J. G., Wang T. C., Wadstrom T. M., Chen D.. Swedish moist snuff accelerates gastric cancer development in Helicobacter pylori-infected wild-type and gastrin transgenic mice. Carcinogenesis. 2007 ; 28: 2041-46
156. Stoltzfus R. J. Iron-deficiency anemia: Reexamining the nature and magnitude of the public health problem. Summary: Implications for research and programs. J Nutr. 2001 ; 131: 697S - 700S
157. Su L., Fontham E., Ruiz B., Schmidt S., Correa P., Bravo L.. Association of dietary antioxidants on the severity of gastritis in a high risk population. Annals Epidemiol. 2000 ; 10: 468
158. Supajatura V., Ushio H., Wada A., Yahiro K., Okumura K., Ogawa H., Hirayama T., Ra C.. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol. 2002 ; 168: 2603-7
159. Suzuki H., Miyazawa M., Nagahashi S., Mori M., Seto K., Kai A., Suzuki M., Miura S., Ishii H.. Attenuated apoptosis in H. pylori-colonized gastric mucosa of Mongolian gerbils in comparison with mice. Dig Dis Sci. 2002 ; 47: 90-99
160. Tajima K., Tominaga S.. Dietary habits and gastro-intestinal cancers: A comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn J Cancer Res. 1985 ; 76: 705-16
161. Takahashi M., Hasegawa R. Diet, Nutrition and Cancer. Hayashi S. Nagao M. Sugimura T., ed. Tokyo, Japan: Japan Scientific Societies Press ; 1986: 169-82.
162. Takahashi M., Kokubo T., Furukawa F., Kurokawa Y., Tatematsu M., Hayashi Y.. Effect of high salt diet on rat gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine. Gann = Gan. 1983 ; 74: 28-34
163. Takaishi S., Cui G., Frederick D. M., Carlson J. E., Houghton J., Varro A., Dockray G. J., Ge Z., Whary M. T., Rogers A. B., Fox J. G., Wang T. C.. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology. 2005 ; 128: 1965-83
164. Takaishi S., Tu S., Dubeykovskaya Z. A., Whary M. T., Muthupalani S., Rickman B. H., Rogers A. B., Lertkowit N., Varro A., Fox J. G., Wang T. C.. Gastrin is an essential cofactor for helicobacter-associated gastric corpus carcinogenesis in C57BL/6 mice. Am J Pathol. 2009 ; 175: 365-75
165. Tammer I., Brandt S., Hartig R., Konig W., Backert S.. Activation of Abl by Helicobacter pylori: A novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology. 2007 ; 132: 1309-19
166. Tan S., Noto J. M., Romero-Gallo J., Peek R. M., Amieva M. R. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS pathogens. 2011 ; 7: e1002050
167. Tatematsu M., Takahashi M., Fukushima S., Hananouchi M., Shirai T.. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. J Natl Cancer Inst. 1975 ; 55: 101-6
168. Taylor P. R.. Prevention of gastric cancer: A miss. J Natl Cancer Inst. 2007 ; 99: 101-3
169. Thompson L. J., Danon S. J., Wilson J. E., O'Rourke J. L., Salama N. R., Falkow S., Mitchell H., Lee A.. Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun. 2004 ; 72: 4668-79
170. Thomson M. J., Pritchard D. M., Boxall S. A., Abuderman A. A., Williams J. M., Varro A., Crabtree J. E.. Gastric Helicobacter infection induces iron deficiency in the INS-GAS mouse. PloS one. 2012 ; 7: e50194
171. Tomita H., Takaishi S., Menheniott T. R., Yang X., Shibata W., Jin G., Betz K. S., Kawakami K., Minamoto T., Tomasetto C., Rio M. C., Lerkowit N., Varro A., Giraud A. S., Wang T. C.. Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology. 2011 ; 140: 879-91
172. Touati E., Michel V., Thiberge J. M., Wuscher N., Huerre M., Labigne A.. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003 ; 124: 1408-19
173. Tsugane S., Akabane M., Inami T., Matsushima S., Ishibashi T., Ichinowatari Y., Miyajima Y., Watanabe S.. Urinary salt excretion and stomach cancer mortality among four Japanese populations. Cancer Causes Control. 1991 ; 2: 165-68
174. Tsugane S., Sasazuki S.. Diet and the risk of gastric cancer: Review of epidemiological evidence. Gastric Cancer. 2007 ; 10: 75-83
175. Tu S., Bhagat G., Cui G., Takaishi S., Kurt-Jones E. A., Rickman B., Betz K. S., Penz-Oesterreicher M., Bjorkdahl O., Fox J. G., Wang T. C.. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer cell. 2008 ; 14: 408-19
176. Tu S., Chi A. L., Lim S., Cui G., Dubeykovskaya Z., Ai W., Fleming J. V., Takaishi S., Wang T. C.. Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways. Am J Physiol Gastrointest Liver Physiol. 2007 ; 292: G1726-37
177. Tummuru M. K., Cover T. L., Blaser M. J.. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun. 1993 ; 61: 1799-809
178. Tuyns A. J.. Salt and gastrointestinal cancer. Nutr Cancer. 1988 ; 11: 229-32
179. Wang S. S., Asfaha S., Okumura T., Betz K. S., Muthupalani S., Rogers A. B., Tu S., Takaishi S., Jin G., Yang X., Wu D. C., Fox J. G., Wang T. C.. Fibroblastic colony-forming unit bone marrow cells delay progression to gastric dysplasia in a helicobacter model of gastric tumorigenesis. Stem Cells. 2009 ; 27: 2301-11
180. Wang T. C., Bonner-Weir S., Oates P. S., Chulak M., Simon B., Merlino G. T., Schmidt E. V., Brand S. J.. Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest. 1993 ; 92: 1349-56
181. Wang L., Chang E. W., Wong S. C., Ong S. M., Chong D. Q., Ling K. L.. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol. 2013 ; 190: 794-804
182. Wang T. C., Dangler C. A., Chen D., Goldenring J. R., Koh T., Raychowdhury R., Coffey R. J., Ito S., Varro A., Dockray G. J., Fox J. G.. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 2000 ; 118: 36-47
183. Wang T. C., Fox J. G.. Helicobacter pylori and gastric cancer: Koch's postulates fulfilled?. Gastroenterology. 1998 ; 115: 780-83
184. Wang T. C., Goldenring J. R., Dangler C., Ito S., Mueller A., Jeon W. K., Koh T. J., Fox J. G.. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology. 1998 ; 114: 675-89
185. Wang T. C., Koh T. J., Varro A., Cahill R. J., Dangler C. A., Fox J. G., Dockray G. J.. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest. 1996 ; 98: 1918-29
186. Wang X. Q., Terry P. D., Yan H.. Review of salt consumption and stomach cancer risk: Epidemiological and biological evidence. World J Gastroenterol. 2009 ; 15: 2204-13
187. Waring A. J., Drake I. M., Schorah C. J., White K. L., Lynch D. A., Axon A. T., Dixon M. F.. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: Effects of gastritis and oral supplementation. GUT. 1996 ; 38: 171-76
188. Watanabe H., Okamoto T., Takahashi T., Ogundigie P. O., Ito A.. The effects of sodium chloride, miso or ethanol on development of intestinal metaplasia after X-irradiation of the rat glandular stomach. Jpn J Cancer Res. 1992 ; 83: 1267-72
189. Watanabe T., Tada M., Nagai H., Sasaki S., Nakao M.. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology. 1998 ; 115: 642-48
190. Diet, nutrition and the prevention of chronic diseases. World Health Organization technical report series. 2003 ; 916: i 1 - viii 149
191. Iron Deficiency Anemia Assessment, Prevention, and Control. Geneva, Switzerland: World Health Organization ; 2001 :
192. Windle H. J., Kelleher D., Crabtree J. E.. Childhood Helicobacter pylori infection and growth impairment in developing countries: A vicious cycle?. Pediatr. 2007 ; 119: e754-59
193. Xiao S. D., Meng X. J., Shi Y., Hu Y. B., Zhu S. S., Wang C. W.. Interventional study of high dose folic acid in gastric carcinogenesis in beagles. GUT. 2002 ; 50: 61-64
194. Yokota K., Kurebayashi Y., Takayama Y., Hayashi S., Isogai H., Isogai E., Imai K., Yabana T., Yachi A., Oguma K.. Colonization of Helicobacter pylori in the gastric mucosa of Mongolian gerbils. Microbiol Immunol. 1991 ; 35: 475-80
195. You W. C., Blot W. J., Chang Y. S., Ershow A. G., Yang Z. T., An Q., Henderson B., Xu G. W., Fraumeni J. F., Wang T. G.. Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 1988 ; 48: 3518-23
196. Zavros Y., Eaton K. A., Kang W., Rathinavelu S., Katukuri V., Kao J. Y., Samuelson L. C., Merchant J. L.. Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene. 2005 ; 24: 2354-66
197. Zeaiter Z., Cohen D., Musch A., Bagnoli F., Covacci A., Stein M.. Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity. Cell Microbiol. 2008 ; 10: 781-94
198. Zimmermann M. B., Hurrell R. F.. Nutritional iron deficiency. Lancet. 2007 ; 370: 511-20
199. Zuniga L. A., Shen W. J., Joyce-Shaikh B., Pyatnova E. A., Richards A. G., Thom C., Andrade S. M., Cua D. J., Kraemer F. B., Butcher E. C.. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010 ; 185: 6947-59
200. Zyromski N. J., Mathur A., Pitt H. A., Wade T. E., Wang S., Nakshatri P., Swartz-Basile D. A., Nakshatri H.. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery. 2009 ; 146: 258-63